Zepbound 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FE779
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,136
Award facts
- Contract value 100% obligated
- $2,136.11 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,136.11 on January 13, 2026, for the supply of Zepbound 7.5 mg/0.5 mL pen injections. This non-competitive delivery order represents a firm fixed-price purchase against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026). The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, with a completion deadline of January 14, 2026. Zepbound is a semaglutide-based injectable medication indicated for weight management, reflecting the federal government's healthcare procurement needs for both military personnel and broader federal medical systems.
AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., serves as a critical pharmaceutical distributor for the Department of Defense and other federal agencies. The company's expansive IDC vehicle enables it to supply a comprehensive range of pharmaceutical products, vaccines, medical devices, and specialized healthcare commodities to support military treatment facilities and veterans' healthcare programs globally. This delivery order exemplifies the routine execution of pharmaceutical supply contracts under the broader DLA medical supply chain framework, which ensures continuous availability of essential medications to federal healthcare beneficiaries.
Quick answers
Who was awarded contract SPE2DR26FE779?
SPE2DR26FE779 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26FE779 worth?
The government has obligated $2,136 on SPE2DR26FE779.
Is contract SPE2DR26FE779 an order under another contract?
Yes. SPE2DR26FE779 is a delivery order under SPE2DR25D1103, an indefinite delivery contract.
Was contract SPE2DR26FE779 competed?
The extent of competition for SPE2DR26FE779 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award